PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Francis I. Proctor Foundation, University of California, San Francisco.\', \'Department of Ophthalmology, University of California, San Francisco.\', \'Department of Epidemiology and Biostatistics, University of California, San Francisco.\', \'Department of Pathology, Stanford University School of Medicine, Stanford, California.\', \'Clinical Virology Laboratory, Stanford Health Care, Stanford, California.\', \'Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford School of Medicine, Stanford, California.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jama.2021.11517
?:hasPublicationType
?:journal
  • JAMA
is ?:pmid of
?:pmid
?:pmid
  • 34269813
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all